(AMD) Advanced Micro Devices - Ratings and Ratios
Microprocessors, GPUs, Accelerators, Embedded-SoCs, Adaptive-SoCs
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 50.9% |
| Value at Risk 5%th | 77.9% |
| Relative Tail Risk | -6.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 40.19 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.443 |
| Beta | 2.007 |
| Beta Downside | 1.844 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.00% |
| Mean DD | 21.29% |
| Median DD | 19.88% |
Description: AMD Advanced Micro Devices December 01, 2025
Advanced Micro Devices (NASDAQ:AMD) is a global semiconductor firm organized into three primary segments-Data Center, Client & Gaming, and Embedded-offering a broad portfolio that includes AI accelerators, x86 CPUs, GPUs, and semi-custom SoCs. Its product families span AMD Ryzen, EPYC, Radeon, Instinct, and a suite of FPGA and adaptive SoC solutions, serving OEMs, cloud providers, system integrators, and distributors worldwide.
In FY 2023 AMD generated roughly $23.5 billion in revenue, driven by a 12% year-over-year increase in EPYC server processor shipments, which now hold about 30% of the hyperscale market. The company’s gross margin hovered near 48%, supported by strong pricing power in AI-focused GPUs where the data-center graphics market is expanding at a CAGR of ~20%. AMD’s R&D outlay exceeded $4.5 billion, reflecting its aggressive push into AI and high-performance computing.
For a deeper dive into AMD’s valuation metrics and peer comparison, check out the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (3.31b TTM) > 0 and > 6% of Revenue (6% = 1.92b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 4.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.77% (prev 46.24%; Δ 1.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 6.41b > Net Income 3.31b (YES >=105%, WARN >=100%) |
| Net Debt (-938.0m) to EBITDA (6.12b) ratio: -0.15 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.64b) change vs 12m ago 0.31% (target <= -2.0% for YES) |
| Gross Margin 48.26% (prev 48.38%; Δ -0.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.71% (prev 34.89%; Δ 8.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 27.01 (EBITDA TTM 6.12b / Interest Expense TTM 114.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.15
| (A) 0.20 = (Total Current Assets 27.00b - Total Current Liabilities 11.70b) / Total Assets 76.89b |
| (B) 0.07 = Retained Earnings (Balance) 5.19b / Total Assets 76.89b |
| (C) 0.04 = EBIT TTM 3.08b / Avg Total Assets 73.26b |
| (D) 0.32 = Book Value of Equity 5.19b / Total Liabilities 16.10b |
| Total Rating: 2.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.86
| 1. Piotroski 6.50pt |
| 2. FCF Yield 1.55% |
| 3. FCF Margin 17.01% |
| 4. Debt/Equity 0.06 |
| 5. Debt/Ebitda -0.15 |
| 6. ROIC - WACC (= -8.88)% |
| 7. RoE 5.61% |
| 8. Rev. Trend 78.61% |
| 9. EPS Trend -18.48% |
What is the price of AMD shares?
Over the past week, the price has changed by -3.30%, over one month by -18.58%, over three months by +32.93% and over the past year by +61.39%.
Is AMD a buy, sell or hold?
- Strong Buy: 25
- Buy: 8
- Hold: 17
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 283.6 | 34.5% |
| Analysts Target Price | 283.6 | 34.5% |
| ValueRay Target Price | 281.5 | 33.6% |
AMD Fundamental Data Overview December 06, 2025
P/E Trailing = 113.0785
P/E Forward = 35.2113
P/S = 10.979
P/B = 5.8276
P/EG = 0.4828
Beta = 1.913
Revenue TTM = 32.03b USD
EBIT TTM = 3.08b USD
EBITDA TTM = 6.12b USD
Long Term Debt = 2.35b USD (from longTermDebt, last quarter)
Short Term Debt = 873.0m USD (from shortTermDebt, last quarter)
Debt = 3.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -938.0m USD (from netDebt column, last quarter)
Enterprise Value = 350.69b USD (351.62b + Debt 3.87b - CCE 4.81b)
Interest Coverage Ratio = 27.01 (Ebit TTM 3.08b / Interest Expense TTM 114.0m)
FCF Yield = 1.55% (FCF TTM 5.45b / Enterprise Value 350.69b)
FCF Margin = 17.01% (FCF TTM 5.45b / Revenue TTM 32.03b)
Net Margin = 10.32% (Net Income TTM 3.31b / Revenue TTM 32.03b)
Gross Margin = 48.26% ((Revenue TTM 32.03b - Cost of Revenue TTM 16.57b) / Revenue TTM)
Gross Margin QoQ = 51.70% (prev 39.80%)
Tobins Q-Ratio = 4.56 (Enterprise Value 350.69b / Total Assets 76.89b)
Interest Expense / Debt = 0.96% (Interest Expense 37.0m / Debt 3.87b)
Taxrate = 11.55% (153.0m / 1.32b)
NOPAT = 2.72b (EBIT 3.08b * (1 - 11.55%))
Current Ratio = 2.31 (Total Current Assets 27.00b / Total Current Liabilities 11.70b)
Debt / Equity = 0.06 (Debt 3.87b / totalStockholderEquity, last quarter 60.79b)
Debt / EBITDA = -0.15 (Net Debt -938.0m / EBITDA 6.12b)
Debt / FCF = -0.17 (Net Debt -938.0m / FCF TTM 5.45b)
Total Stockholder Equity = 58.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.30% (Net Income 3.31b / Total Assets 76.89b)
RoE = 5.61% (Net Income TTM 3.31b / Total Stockholder Equity 58.98b)
RoCE = 5.02% (EBIT 3.08b / Capital Employed (Equity 58.98b + L.T.Debt 2.35b))
RoIC = 4.39% (NOPAT 2.72b / Invested Capital 62.06b)
WACC = 13.27% (E(351.62b)/V(355.49b) * Re(13.41%) + D(3.87b)/V(355.49b) * Rd(0.96%) * (1-Tc(0.12)))
Discount Rate = 13.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.40%
[DCF Debug] Terminal Value 58.50% ; FCFE base≈3.89b ; Y1≈3.46b ; Y5≈2.91b
Fair Price DCF = 16.10 (DCF Value 26.21b / Shares Outstanding 1.63b; 5y FCF grow -13.60% → 3.0% )
EPS Correlation: -18.48 | EPS CAGR: -5.30% | SUE: 0.34 | # QB: 0
Revenue Correlation: 78.61 | Revenue CAGR: 18.93% | SUE: 0.86 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.20 | Chg30d=-0.016 | Revisions Net=-3 | Analysts=34
EPS next Year (2026-12-31): EPS=6.44 | Chg30d=+0.093 | Revisions Net=+18 | Growth EPS=+62.4% | Growth Revenue=+31.1%
Additional Sources for AMD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle